News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Rhodes Jason P
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| Rhodes Jason P (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Granted 25,000 options to buy
@ $4.83, valued at
$120.8k
|
|
| 05/25/2023 |
4
| Rhodes Jason P (Director) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Granted 24,900 options to buy
@ $13.49, valued at
$335.9k
|
|
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Rhodes Jason P (Director) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 16,500 options to buy
@ $18.26, valued at
$301.3k
|
|
| 10/06/2021 |
4
| Rhodes Jason P (10% Owner) has filed a Form 4 on Gemini Therapeutics, Inc. /DE|
Txns:
| Granted 17,245 options to buy
@ $3.8, valued at
$65.5k
|
|
| 09/29/2021 |
4
| Rhodes Jason P (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Sold 51,294 shares
@ $25.7, valued at
$1.3M
Sold 95 shares
@ $25.7, valued at
$2.4k
Sold 13,089 shares
@ $25.24, valued at
$330.4k
Sold 24 shares
@ $25.24, valued at
$605.8
Sold 16,556 shares
@ $24.59, valued at
$407.1k
Sold 30 shares
@ $24.59, valued at
$737.7 |
|
| 09/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Rhodes Jason P (Director) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Granted 19,596 options to buy
@ $19.56, valued at
$383.3k
|
|
| 04/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2021 |
3
| Rhodes Jason P (Director) has filed a Form 3 on Gemini Therapeutics, Inc. /DE |
| 01/28/2021 |
4
| Rhodes Jason P (Director) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 5,558 shares
@ $46.14, valued at
$256.4k
|
|
| 12/22/2020 |
4
| Rhodes Jason P (Director) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 3,012 shares
@ $41.95, valued at
$126.4k
Sold 1,042 shares
@ $41.95, valued at
$43.7k
Sold 265 shares
@ $41.95, valued at
$11.1k
|
|
| 12/17/2020 |
4
| Rhodes Jason P (Director) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 28,078 shares
@ $42.4, valued at
$1.2M
Sold 349 shares
@ $43.12, valued at
$15k
Sold 70 shares
@ $44.08, valued at
$3.1k
Sold 9,710 shares
@ $42.4, valued at
$411.7k
Sold 120 shares
@ $43.12, valued at
$5.2k
Sold 24 shares
@ $44.08, valued at
$1.1k
Sold 2,432 shares
@ $42.4, valued at
$103.1k
Sold 30 shares
@ $43.12, valued at
$1.3k
Sold 6 shares
@ $44.08, valued at
$264.5
Sold 8,849 shares
@ $42.13, valued at
$372.8k
Sold 3,060 shares
@ $42.13, valued at
$128.9k
|
|
| 12/14/2020 |
4
| Rhodes Jason P (Director) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 12,691 shares
@ $42.68, valued at
$541.7k
Sold 8,666 shares
@ $43.48, valued at
$376.8k
Sold 2,653 shares
@ $44.35, valued at
$117.7k
Sold 4,389 shares
@ $42.68, valued at
$187.3k
Sold 2,996 shares
@ $43.48, valued at
$130.3k
Sold 917 shares
@ $44.35, valued at
$40.7k
Sold 1,099 shares
@ $42.68, valued at
$46.9k
Sold 750 shares
@ $43.48, valued at
$32.6k
Sold 230 shares
@ $44.35, valued at
$10.2k
Sold 19,712 shares
@ $43.32, valued at
$853.9k
Sold 2,374 shares
@ $43.92, valued at
$104.3k
|
|
| 12/09/2020 |
4
| Rhodes Jason P (Director) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 8,636 shares
@ $45.46, valued at
$392.6k
Sold 23,174 shares
@ $45.97, valued at
$1.1M
Sold 1,222 shares
@ $46.91, valued at
$57.3k
Sold 2,962 shares
@ $45.45, valued at
$134.6k
Sold 26,713 shares
@ $46.06, valued at
$1.2M
Sold 2,322 shares
@ $46.93, valued at
$109k
Sold 748 shares
@ $45.46, valued at
$34k
Sold 2,007 shares
@ $45.97, valued at
$92.3k
Sold 106 shares
@ $46.91, valued at
$5k
Sold 7,001 shares
@ $46.02, valued at
$322.2k
Sold 33,133 shares
@ $46.94, valued at
$1.6M
|
|
| 09/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2020 |
3
| Rhodes Jason P (10% Owner) has filed a Form 3 on Dyne Therapeutics, Inc. |
| 06/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| Rhodes Jason P (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Granted 52,000 options to buy
@ $19, valued at
$988k
|
|
| 06/11/2020 |
3
| Rhodes Jason P (Director) has filed a Form 3 on Generation Bio Co. |
| 04/02/2020 |
4
| Rhodes Jason P (Director) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 16,500 options to buy
@ $9.78, valued at
$161.4k
|
|
| 11/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2018 |
4
| Rhodes Jason P (Director) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Converted 3,439,839 shares
@ $0
Converted 1,013,547 shares
@ $0
Converted 3,439,839 convertible preferred
@ $0
Converted 1,013,547 convertible preferred
@ $0
Granted 13,500 options to buy
@ $15, valued at
$202.5k
|
|
| 07/19/2018 |
3
| Rhodes Jason P (Director) has filed a Form 3 on Replimune Group, Inc. |
|
|